Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 138   

Articles published

GSK 1,411.28 -1.22 (-0.09%)
price chart
Neil Woodford Sells GlaxoSmithKline plc — But Don't Panic!
Ace fund manager Neil Woodford has long had FTSE 100 pharma giant GlaxoSmithKline (LSE: GSK) as a core holding, and has been singing the company's praises for as long as I can remember.
Do Today's Results Make GlaxoSmithKline plc A Contrarian Buy?
Shares in GlaxoSmithKline (LSE: GSK) have risen modestly so far this afternoon, despite the company reporting a 21% fall in core earnings for 2015.
GSK - GlaxoSmithKline plc: Results announcement for the fourth quarter 2015  The Wall Street Transcript
GlaxoSmithKline pots 354 million pounds loss  MarketWatch
22935 Shares in GlaxoSmithKline plc (GSK) Acquired by Capital Fund Management S.A.
GlaxoSmithKline plc logo Capital Fund Management S.A. purchased a new stake in shares of GlaxoSmithKline plc (NYSE:GSK) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
GlaxoSmithKline plc (GSK) Given Neutral Rating at JPMorgan Chase & Co.  Intercooler Financial
GlaxoSmithKline plc (GSK) Shares Sold by Douglass Winthrop Advisors LLC  Daily Political
Why GlaxoSmithKline plc, Aviva plc & Trifast plc Are Beaming Bargains!
General insurance giant Aviva (LSE: AV) hasn't been immune to the weak risk appetite washing across financial markets, and the business has seen its shares fall 13% since the turn of the year.
Should You Buy GlaxoSmithKline plc, AstraZeneca plc & Hargreaves Lansdown plc ...
I don't know about you, but I for one am glad to see the back of January. Despite my personal portfolio's small-cap growth-oriented construction, I've been along for the ride on the turbulent market roller coaster.
GlaxoSmithKline plc (GSK) Price Target Increased to $45.00 by Analysts at ...
GlaxoSmithKline plc logo GlaxoSmithKline plc (NYSE:GSK) had its target price upped by Sanford C. Bernstein from $43.00 to $45.00 in a research report report published on Thursday morning, StockTargetPrices.
GlaxoSmithKline plc 13.8% Potential Upside Indicated by Barclays Capital  DirectorsTalk Interviews
GlaxoSmithKline plc (GSK) Given a GBX 1450 Price Target at Morgan Stanley  Intercooler Financial
GlaxoSmithKline plc Can Pull Through Without a Split; Merrill Lynch Hikes ...
This Wednesday, GlaxoSmithKline plc (ADR) (NYSE:GSK) managed to deliver a slight fourth-quarter earnings beat, aided by increasing demand for its recently launched respiratory and HIV medicines.
GlaxoSmithKline plc And Smith & Nephew plc: Healthy Stock Stars For Your ...
Despite the sterling work achieved by its R&D department over the past year, drugs giant GlaxoSmithKline (LSE: GSK) is still struggling to overcome insipid investor appetite. Shares in the firm have tracked 15% lower from last April's peaks of around ...
GlaxoSmithKline plc: Next Stop 1600P
After nearly a year of giving GlaxoSmithKline (LSE: GSK) a wide berth, the market finally seems to be waking up to the company's potential.
Are Diageo plc, British American Tobacco plc & GlaxoSmithKline plc Safe Ports ...
Investors can be forgiven for wanting to find safe ports in today's market storms, but it isn't always easy. When the market is hit by a force 10 gale, there are few protected harbours.